Navigation Links
New approach to anti-anxiety drugs

Researchers have found that lack of a brain protein makes mice notably less anxious and may extend the findings to humans with anxiety disorders. Anxiety is a natural human response to life,// but when it gets out of hand it can inhibit everyday behaviour and cause much suffering. Around 15 million people might have had the necessity for anxiety related treatment. The anti-anxiety drugs have always been very effective in such needy times. The major class is known as the benzodiazepines but these have the drawback of causing sedation that may make it hard to function. They also have the potential to cause addiction. Researchers at the University of North Carolina, and others, now report that they have found a potential new target for anti-anxiety drugs.

They've been looking at mice genetically altered so they don't produce a natural brain protein called protein kinase C. These mice seem to be more sensitive to the brain's own sedative molecules, known as neurosteroids. They are less fearful of heights and open spaces (a test of anxiety in mice). The researchers wonder if creating inhibitors for protein kinase C would be a useful way forward for treating anxiety in humans, providing an alternative to the benzodiazepines.


'"/>




Page: 1

Related medicine news :

1. Fresh approach to TB treatment
2. More signs to an approaching migraine attack
3. Gene enchances radiation therapy - A novel approach to fight cancer
4. Combined modality approach for effective treatment and enhanced survival in bile duct cancer
5. A new approach to vaginal hysterectomy
6. Multi targeted approach required for suicide prevention in adolescents
7. Mathematical approach to asthma
8. Trident approach reduces malaria in HIV patients
9. A Novel approach in Malaria treatment
10. Cancer drugs in development nearly doubled since 1995
11. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/22/2017)... SAN DIEGO , Sept. 22, 2017 ... ll medical device is now successfully helping those with ... Union. Fibromyalgia diagnosed Amanda in ... getting dressed and washing my hair, experiencing no sleep ... body in painful spasm… I cannot recommend [the AVACEN ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: